Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Sep;62(3):395–397. doi: 10.1038/bjc.1990.305

Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice.

B Chauffert 1, H Pelletier 1, C Corda 1, E Solary 1, L Bedenne 1, D Caillot 1, F Martin 1
PMCID: PMC1971452  PMID: 2206948

Abstract

Quinine, the widely used antimalaria agent, was found to increase the cytotoxicity of epideoxorubicin (epiDXR) in resistant DHD/K12 rat colon cancer cells in vitro. Quinine appeared as slightly less effective than quinidine or verapamil for anthracycline potentiation but its weaker cardiotoxicity could counterbalance this disadvantage in vivo. Serum from six patients treated by conventional doses of quinine (25-30 mg kg-1 day-1) was demonstrated to enhance the accumulation of epiDXR in DHD/K12 cells as judged by fluorescence microscopy and HPLC assay (1.6 to 6-fold compared with control serum). In this patients quinine concentrations in serum ranged from 4.4 to 10.1 micrograms ml-1. Our results suggest that quinine could be safely used as anthracycline resistance modifier in clinical practice.

Full text

PDF
396

Images in this article

396Figure 2
on p.396

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson A. B., 3rd, Trump D. L., Koeller J. M., Egorin M. I., Olman E. A., Witte R. S., Davis T. E., Tormey D. C. Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):795–799. [PubMed] [Google Scholar]
  2. Boland M. E., Roper S. M., Henry J. A. Complications of quinine poisoning. Lancet. 1985 Feb 16;1(8425):384–385. doi: 10.1016/s0140-6736(85)91398-4. [DOI] [PubMed] [Google Scholar]
  3. Chauffert B., Martin F., Caignard A., Jeannin J. F., Leclerc A. Cytofluorescence localization of adriamycin in resistant colon cancer cells. Cancer Chemother Pharmacol. 1984;13(1):14–18. doi: 10.1007/BF00401439. [DOI] [PubMed] [Google Scholar]
  4. Chauffert B., Martin M., Hammann A., Michel M. F., Martin F. Amiodarone-induced enhancement of doxorubicin and 4'-deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo. Cancer Res. 1986 Feb;46(2):825–830. [PubMed] [Google Scholar]
  5. Dalton W. S., Grogan T. M., Meltzer P. S., Scheper R. J., Durie B. G., Taylor C. W., Miller T. P., Salmon S. E. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol. 1989 Apr;7(4):415–424. doi: 10.1200/JCO.1989.7.4.415. [DOI] [PubMed] [Google Scholar]
  6. Goldstein L. J., Galski H., Fojo A., Willingham M., Lai S. L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G. M. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 1989 Jan 18;81(2):116–124. doi: 10.1093/jnci/81.2.116. [DOI] [PubMed] [Google Scholar]
  7. Gottesman M. M., Pastan I. Clinical trials of agents that reverse multidrug-resistance. J Clin Oncol. 1989 Apr;7(4):409–411. doi: 10.1200/JCO.1989.7.4.409. [DOI] [PubMed] [Google Scholar]
  8. Hall A. P. The treatment of malaria. Br Med J. 1976 Feb 7;1(6005):323–328. doi: 10.1136/bmj.1.6005.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holford N. H., Coates P. E., Guentert T. W., Riegelman S., Sheiner L. B. The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships. Br J Clin Pharmacol. 1981 Feb;11(2):187–195. doi: 10.1111/j.1365-2125.1981.tb01123.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Martin F., Caignard A., Olsson O., Jeannin J. F., Leclerc A. Tumoricidal effect of macrophages exposed to adriamycin in vivo or in vitro. Cancer Res. 1982 Sep;42(9):3851–3857. [PubMed] [Google Scholar]
  11. Martin F., Knobel S., Martin M., Bordes M. A carcinofetal antigen located on the membrane of cells from rat intestinal carcinoma in culture. Cancer Res. 1975 Feb;35(2):333–336. [PubMed] [Google Scholar]
  12. Ochs H. R., Greenblatt D. J., Woo E. Clinical pharmacokinetics of quinidine. Clin Pharmacokinet. 1980 Mar-Apr;5(2):150–168. doi: 10.2165/00003088-198005020-00003. [DOI] [PubMed] [Google Scholar]
  13. Oliver M. H., Harrison N. K., Bishop J. E., Cole P. J., Laurent G. J. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci. 1989 Mar;92(Pt 3):513–518. doi: 10.1242/jcs.92.3.513. [DOI] [PubMed] [Google Scholar]
  14. Schomerus M., Spiegelhalder B., Stieren B., Eichelbaum M. Physiological disposition of verapamil in man. Cardiovasc Res. 1976 Sep;10(5):605–612. doi: 10.1093/cvr/10.5.605. [DOI] [PubMed] [Google Scholar]
  15. Silamut K., White N. J., Looareesuwan S., Warrell D. A. Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg. 1985 Jul;34(4):681–686. doi: 10.4269/ajtmh.1985.34.681. [DOI] [PubMed] [Google Scholar]
  16. Slater L. M., Sweet P., Stupecky M., Wetzel M. W., Gupta S. Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br J Cancer. 1986 Aug;54(2):235–238. doi: 10.1038/bjc.1986.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tsuruo T., Iida H., Kitatani Y., Yokota K., Tsukagoshi S., Sakurai Y. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res. 1984 Oct;44(10):4303–4307. [PubMed] [Google Scholar]
  18. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982 Nov;42(11):4730–4733. [PubMed] [Google Scholar]
  19. White N. J., Looareesuwan S., Warrell D. A., Warrell M. J., Bunnag D., Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. Am J Med. 1982 Oct;73(4):564–572. doi: 10.1016/0002-9343(82)90337-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES